Medical Weight Loss for Omaha, Nebraska Residents
Omaha, Nebraska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Omaha through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Omaha Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Omaha, Nebraska residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Omaha is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-up all happen by secure video, no travel required.
In Omaha, Nebraska, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Downtown, the Old Market, Dundee, Benson, and the greater Omaha metro. Every prescription for Omaha is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Whether you live in central Omaha or its outskirts, you get exactly the same care and the same price. Pricing for Omaha is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month · just $7.70/day for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Omaha patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Omaha
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Omaha address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Omaha
Does New Hope Weight Loss treat patients in Omaha?
Yes. Although the clinic is in Costa Mesa, California, we treat Omaha, Nebraska residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Omaha?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Omaha address in cold-pack packaging.
What do Omaha patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Omaha do you serve?
We serve patients from across Omaha by telehealth, including Downtown, the Old Market, Dundee, Benson, and the greater Omaha metro.
Does the program cost more for Omaha patients because of shipping?
No. Pricing is the same nationwide: a $119 physician visit and compounded semaglutide from $166/month, medication billed separately. Cold-pack shipping to Omaha is part of the standard process, no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Omaha, Nebraska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.